Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a First-Line Tumor Necrosis Factor Inhibitor in the United States.
Saved in:
| Title: | Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a First-Line Tumor Necrosis Factor Inhibitor in the United States. |
|---|---|
| Authors: | Charles-Schoeman, Christina1 (AUTHOR) ccharles@mednet.ucla.edu, Zueger, Patrick2 (AUTHOR), McDearmon-Blondell, Erin2 (AUTHOR), Fang, Siran2 (AUTHOR), Peng, Yi2 (AUTHOR), Oishi, Tanjinatus2 (AUTHOR), Jain, Manish3 (AUTHOR), Tesser, John4 (AUTHOR) |
| Source: | Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p95-114. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
